22 reports

It was approved in 1973 for the treatment of asthma, COPD and bronchospasm in the US and EU.

  • Tuberculosis
  • World
  • Market Size
  • Actelion Ltd
  • Pfizer Inc.
  • Technology Development

The clinic applications of the said new drug at Beijing XiYuan Hospital have confirmed its numerous pharmacological functions such as bacteria resistance; cough relieving, asthma suppressing, phlegm dissolving and immunity enhancing.

  • Tuberculosis
  • China
  • Demand
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Technology Development

The clinic applications of the said new drug at Beijing XiYuan Hospital have confirmed its numerous pharmacological functions such as bacteria resistance; cough relieving, asthma suppressing, phlegm dissolving and immunity enhancing.

  • Tuberculosis
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Shenyang Shuangding Pharmaceutical Co., Ltd.
  • RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2016 VS. 2021
  • THE TUBERCULOSIS DISEASE SEGMENT TO DOMINATE THE RESPIRATORY

THE GLOBAL ASTHMA REPORT 2014 BY THE GLOBAL ASTHMA NETWORK (GAN) STATED THAT AROUND ## MILLION PEOPLE GLOBALLY WERE SUFFERING FROM ASTHMA IN 2012.

  • Tuberculosis
  • North America
  • United States
  • Market Size
  • Alere Inc.

" We interviewed parents with a standardized questionnaire to see if their child had experienced side effects with asthma medications and, if so, to identify which ones and circumstances related to the event, " says Dr.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Tuberculosis
  • Canada

NO has a solid place in asthma management.

  • Drug Test
  • Tuberculosis
  • United States
  • Alere Inc.
  • Dräger Group

CS-## was under development for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

  • Breast Cancer
  • Monoclonal Antibody
  • Therapy
  • Tuberculosis
  • Daiichi Sankyo Company
  • QURETECH BIO AB
  • TUBERCULOSIS - PIPELINE BY QURETECH BIO AB, H2 2017

The company is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR)/ multi drug resistant (MDR)/ totally drug resistant (TDR) tuberculosis (TB); asthma and cancer.

  • Pathology
  • Tuberculosis
  • Vaccine
  • World
  • TB Drug Development, Inc.

Mundipharma Mundipharma Medical Company (MMCO) is a pharmaceutical company whose core areas are pain management and palliative care, disinfection and wound treatment and the treatment of asthma.

  • Tuberculosis
  • Belgium
  • United States
  • Company
  • Janssen Biotech, Inc.
  • 4.2.2 MRSA

PLOS ONE; ##(##): ##-## Fair RJ and Tor Y (2014).

  • Anti-Infective
  • Therapy
  • Tuberculosis
  • World
  • Deals & Alliance
  • 5. All the trials included are unique trials.

## ## ## ## ## ## Sanofi Otsuka Holdings Co Ltd Cadila Pharmaceuticals Ltd IQVIA Holdings Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## ## ## Sequella Inc

  • Anti-Infective
  • Clinical Trial
  • Tuberculosis
  • World
  • Product Initiative
  • TUBERCULOSIS FEATURED NEWS & PRESS RELEASES

Its KETAS is a phosphodiesterase inhibitor agent for ameliorating bronchial asthma and cerebro-vascular disorders.

  • Biotech
  • Tuberculosis
  • United States
  • Company
  • Product Initiative
  • 3. GDCT ID is the unique ID of GlobalData's Pharma Intelligence Center clinical trial database

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Pharmaceutical
  • Tuberculosis
  • World
  • Clinical Trial profile. 577 Trial Title
  • Clinical Trial profile. 572 Trial Title

The prominent features of this report are - ##.

  • Anti-Infective
  • Clinical Trial
  • Infectious Disease
  • Tuberculosis
  • World
  • QURIENT CO LTD
  • TUBERCULOSIS - PIPELINE BY QURIENT CO LTD, H1 2018

It is also developing new approaches to the treatment of asthma.

  • Pathology
  • Tuberculosis
  • Vaccine
  • United States
  • TB Drug Development, Inc.
  • Mycobacterium tuberculosis Protein Ag85A - Featured News & Press Releases

The difficulty of this task is one reason why there has not been a new TB vaccine since BCG was developed more than ## years ago, but one is still urgently needed and I' m not about to give up now. "

  • Tuberculosis
  • Vaccine
  • South Africa
  • World
  • Product Initiative

It was also under development for asthma.

  • Blood Disease
  • Therapy
  • Tuberculosis
  • United States
  • AstraZeneca PLC

As of February 2012, it was in Phase II for asthma.

  • Cancer
  • Targeted Therapy
  • Therapy
  • Tuberculosis
  • Novartis AG

To u. ##-##.

  • Infectious Disease
  • Therapy
  • Tuberculosis
  • United States
  • Sanofi S.A.
  • Syntrix Biosystems, Inc. - Pipeline by Indication, 2015

Syntrix Biosystems, Inc. is developing of SX-## for the treatment of severe asthma.

  • Tuberculosis
  • Turkey
  • United States
  • Company Operations
  • Syntrix Biosystems, Inc.

UPDATE ON SOUTH AFRICA' S BURDEN OF DISEASE ##.

  • Healthcare
  • Hospital
  • Tuberculosis
  • South Africa
  • Netcare Limited

The company is developing a pipeline of novel therapies to treat serious diseases such as chronic obstructive pulmonary disease (COPD), severe steroid-insensitive asthma, allergic asthma, and cystic fibrosis (CF).

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Tuberculosis
  • BioFocus DPI Limited